Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
McKesson
Medtronic
Express Scripts
Baxter

Last Updated: June 10, 2023

Celltrion Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for CELLTRION, and what generic and branded alternatives to CELLTRION drugs are available?

CELLTRION has eighteen approved drugs.



Drugs and US Patents for Celltrion

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Celltrion DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 077296-002 Jul 31, 2008 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Celltrion CLOPIDOGREL BISULFATE clopidogrel bisulfate TABLET;ORAL 202266-002 Nov 20, 2012 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Celltrion PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 076798-002 Oct 26, 2012 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Celltrion ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET, EXTENDED RELEASE;ORAL 091395-004 Aug 27, 2012 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Celltrion LEVOFLOXACIN levofloxacin TABLET;ORAL 090367-002 Jun 20, 2011 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Celltrion DROXIDOPA droxidopa CAPSULE;ORAL 214217-003 May 5, 2022 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Celltrion LEVOFLOXACIN levofloxacin TABLET;ORAL 090367-003 Jun 20, 2011 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Medtronic
Dow
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.